Cancer is frequently associated with anorexia, weight loss, negative nitrog
en balance, and skeletal-muscle wasting. Depletion of skeletal-muscle mass
is critical to overall survival of the patient, can prolong rehabilitation
to normal function after recovery, and decreases quality of life in a palli
ative-care setting; The biochemical and physiologic bases of cancer-associa
ted muscle wasting have been most fully investigated in animal models. Thes
e studies provide evidence for suppressed protein synthesis and activated p
roteolysis in cancer-associated muscle wasting and indicate a need for both
anabolic and anticatabolic therapies. Several;humoral factors of host or t
umor origin are implicated in altered muscle-protein metabolism, including
cytokines, metabolites of arachidonic acid, and a proteolysis-inducing glyc
oprotein; their interrelationships are less well characterized. Several cat
abolic mediators may share common downstream mechanisms because they ultima
tely activate the ATP-, ubiquitin-, and proteasome-dependent intracellular
proteolytic system. Although important gaps in our current understanding re
main, data available from animal studies can be used as a basis to develop
relevant studies in human subjects. Nutrition 2000;16:1015-1018. (C) Elsevi
er Science Inc. 2000.